Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suppression of NNK Metabolism by Anthocyanin-Rich Haskap Berry Supplementation Through Modulation of P450 Enzymes.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation.

Biomolecules·2024
Same author

Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells.

International journal of molecular sciences·2023
Same author

Iron Withdrawal with DIBI, a Novel 3-Hydroxypyridin-4-One Chelator Iron-Binding Polymer, Attenuates Macrophage Inflammatory Responses.

Advanced pharmaceutical bulletin·2023
Same author

Anthocyanin Encapsulated Nanoparticles as a Pulmonary Delivery System.

Oxidative medicine and cellular longevity·2022
Same author

Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach.

Life (Basel, Switzerland)·2022

Related Experiment Video

Updated: Mar 9, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

3.0K

Protocols for Studying Antimicrobial Peptides (AMPs) as Anticancer Agents.

Laurence Madera1, David W Hoskin2,3,4

  • 1Department of Microbiology and Immunology, Dalhousie University, 5850 College Street, 1500, Halifax, NS, Canada, B3H 4R2.

Methods in Molecular Biology (Clifton, N.J.)
|December 26, 2016
PubMed
Summary

Antimicrobial peptides (AMPs) show selective toxicity against cancer cells by damaging their membranes. These peptides offer a promising avenue for developing novel anticancer therapeutics, with established methods to evaluate their efficacy.

Keywords:
AngiogenesisAntimicrobial peptideApoptosisCancerCytolysisMetastasisMitochondria

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.2K

Related Experiment Videos

Last Updated: Mar 9, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

3.0K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.2K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Antimicrobial peptides (AMPs) are crucial for host defense.
  • AMPs exhibit selective cytotoxicity towards cancer cells due to their anionic lipid membranes, unlike healthy cells with neutral membranes.
  • This selective action positions AMPs as potential anticancer therapeutic agents.

Purpose of the Study:

  • To detail methodologies for evaluating the anticancer potential of AMPs.
  • To assess the impact of AMPs on cancer cell viability, function, and key cancer-related processes.

Main Methods:

  • Propidium iodide uptake assay for cell membrane damage.
  • Annexin V-FLUOS/propidium iodide staining for apoptosis and necrosis.
  • 3,3'-dihexyloxacarbocyanine iodide staining for mitochondrial membrane destabilization.
  • Migration and invasion assays for cell motility.
  • Tubule-forming assay for angiogenesis assessment.

Main Results:

  • The described methods allow for comprehensive evaluation of AMP effects on cancer cells.
  • Specific assays quantify membrane damage, cell death pathways, mitochondrial integrity, and cell migration.
  • The tubule assay assesses AMPs' impact on the formation of new blood vessels.

Conclusions:

  • Established methods are vital for developing AMPs as anticancer drugs.
  • These assays provide a framework for understanding AMP mechanisms and optimizing their therapeutic use.
  • AMPs represent a promising class of compounds for targeted cancer therapy.